AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
141.65
-0.93 (-0.65%)
At close: Feb 17, 2026, 4:00 PM EST
141.65
0.00 (0.00%)
After-hours: Feb 17, 2026, 4:10 PM EST
AptarGroup Employees
AptarGroup had 14,000 employees as of December 31, 2025. The number of employees increased by 500 or 3.70% compared to the previous year.
Employees
14,000
Change (1Y)
500
Growth (1Y)
3.70%
Revenue / Employee
$269,799
Profits / Employee
$28,056
Market Cap
9.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14,000 | 500 | 3.70% |
| Dec 31, 2024 | 13,500 | -300 | -2.17% |
| Dec 31, 2023 | 13,800 | 300 | 2.22% |
| Dec 31, 2022 | 13,500 | 500 | 3.85% |
| Dec 31, 2021 | 13,000 | 0 | - |
| Dec 31, 2020 | 13,000 | -1,000 | -7.14% |
| Dec 31, 2019 | 14,000 | -100 | -0.71% |
| Dec 31, 2018 | 14,100 | 900 | 6.82% |
| Dec 31, 2017 | 13,200 | 500 | 3.94% |
| Dec 31, 2016 | 12,700 | -300 | -2.31% |
| Dec 31, 2015 | 13,000 | 0 | - |
| Dec 31, 2014 | 13,000 | 600 | 4.84% |
| Dec 31, 2013 | 12,400 | 400 | 3.33% |
| Dec 31, 2012 | 12,000 | 1,100 | 10.09% |
| Dec 31, 2011 | 10,900 | 2,300 | 26.74% |
| Dec 31, 2010 | 8,600 | -100 | -1.15% |
| Dec 31, 2009 | 8,700 | 0 | - |
| Dec 31, 2008 | 8,700 | 300 | 3.57% |
| Dec 31, 2007 | 8,400 | 200 | 2.44% |
| Dec 31, 2006 | 8,200 | 1,000 | 13.89% |
| Dec 31, 2005 | 7,200 | 400 | 5.88% |
| Dec 31, 2004 | 6,800 | 200 | 3.03% |
| Dec 31, 2003 | 6,600 | -100 | -1.49% |
| Dec 31, 2002 | 6,700 | 100 | 1.52% |
| Dec 31, 2001 | 6,600 | 200 | 3.13% |
| Dec 31, 2000 | 6,400 | 200 | 3.23% |
| Dec 31, 1999 | 6,200 | 500 | 8.77% |
| Dec 31, 1998 | 5,700 | 1,600 | 39.02% |
| Dec 31, 1997 | 4,100 | 200 | 5.13% |
| Dec 31, 1996 | 3,900 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Baxter International | 37,500 |
| Solventum | 22,000 |
| Align Technology | 20,945 |
| The Cooper Companies | 15,000 |
| Avantor | 13,500 |
| Bausch + Lomb | 13,500 |
| Envista Holdings | 12,300 |
| West Pharmaceutical Services | 10,600 |
ATR News
- 11 days ago - AptarGroup, Inc. (ATR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Aptar Reports Fourth Quarter and Annual 2025 Results - Business Wire
- 25 days ago - Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details - Business Wire
- 26 days ago - Aptar Again Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment - Business Wire
- 4 weeks ago - AptarGroup, Inc. (ATR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Aptar Announces 2026 Quarterly Conference Call Dates - Business Wire
- 6 weeks ago - Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Business Wire
- 2 months ago - Aptar's Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Business Wire